Street Highjack By Active Movers: Westinghouse Air Brake Technologies (NYSE:WAB), Applied Materials (NASDAQ:AMAT)

Westinghouse Air Brake Technologies Corporation (NYSE:WAB) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 1.62% to $86.04. Westinghouse Air Brake Technologies Corp., doing business as Wabtec Corp. (WAB), reported that it has purchased Faiveley family’s about 51 percent stake in Faiveley Transport S.A. for about $212 million in cash and 6.3 million Wabtec shares. The firm plans to launch a tender offer for the remaining public shares in December.

Through the tender offer, the public shareholders of Faiveley Transport will have the option to elect to receive 100 euros per share of Faiveley Transport in cash or 1.1538 Wabtec ordinary shares per share of Faiveley Transport. The total purchase price for 100% of the shares of Faiveley Transport is about $1.7 billion, comprising assumed debt and net of cash takeoverd. The share price of WAB attracts active investors, as stock price of week volatility recorded 1.67%. The stock is going forward to its 52-week low with 43.45% and lagging behind from its 52-week high price with -2.75%.

Applied Materials, Inc. (NASDAQ:AMAT) [Trend Analysis] moved down reacts as active mover, shares a loss -6.52% to traded at $30.10 and the percentage gap among open changing to regular change was -0.19%. Applied Materials, Inc. released that its BOD has agreed a quarterly cash dividend of $0.10 per share payable on the firm’s ordinary stock.

The dividend is payable on March 15, 2017 to shareholders of record as of February 22, 2017. The firm’s current ratio calculated as 2.30 for the most recent quarter. The firm past twelve months price to sales ratio was 3.01 and price to cash ratio remained 8.68. As far as the returns are concern, the return on equity was recorded as 24.80% and return on investment was 17.60% while its return on asset stayed at 12.60%. The firm has total debt to equity ratio measured as 0.46.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *